SPStephen W Pedersen

Stephen W Pedersen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stephen W Pedersen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Alison Forbes

    PDNS consultant, AbbVie Inc., Roswell, GA, USA

    1 shared publication
  • Ashley Yegin

    Global Medical Affairs, AbbVie Inc., North Chicago, IL, USA

    1 shared publication
  • Dirk Domagk

    Department of Medicine I, Josephs-Hospital Warendorf, Academic Teaching Hospital, University of Muenster, Warendorf, Germany

    1 shared publication
  • Koray Onuk

    Global Medical Affairs, AbbVie Inc., North Chicago, IL, USA

    1 shared publication
  • Lars Bergmann

    Global Medical Affairs, AbbVie Inc., North Chicago, IL, USA

    1 shared publication
  • Louis W C Liu

    Division of Gastroenterology, Department of Medicine, University of Toronto, University Health Network, Toronto, ON, Canada

    1 shared publication

Latest Publications

  • Open Access

    The role and structure of the multidisciplinary team in the management of advanced Parkinson’s disease with a focus on the use of levodopa–carbidopa intestinal gel

    by Stephen W Pedersen, Martin Suedmeyer, Louis W C Liu, Dirk Domagk, Alison Forbes, Lars Bergmann, Koray Onuk, Ashley Yegin, Teus van Laar

    A multidisciplinary team (MDT) approach is increasingly recommended in Parkinson’s disease (PD) treatment guidelines, but no standard of care exists for such an approach, and the guidelines do not provide clarification on how it should be implemented. This paper reviews evidence of MDT interventions in people with PD and provides expert clinical perspectives for an MDT approach, with a focus on advanced PD and levodopa–carbidopa intestinal gel (carbidopa–levodopa enteral suspension in the USA). The key recommendations are to enable the best possible treatment of people with PD locally by facilitating a close structured collaboration of different health care professionals working in a fixed network structure; to refer people with PD to established MDT centers in a timely manner; to establish regular meetings for the MDT enabling interdisciplinary exchange and learning; to optimize individual treatment and carefully evaluate available treatment options; to ensure treatment decisions are agreed jointly between people with PD, their caregivers, family, and health care professional; and to include specialists outside of neurology from adjuvant medical departments as necessary when implementing advanced therapies.